Foresite Capital portfolio

Foresite Capital (Venture capital) is known to hold 134 companies, 39 of them startups. 63 of them are hiring now, with 1,055 open roles. In the last 12 months rounds in the press named it 2 times (1 as the lead). Its companies closed 10 venture rounds in 12 months, raising $439M. Most of them work in Prescription Drugs, Oncology Therapeutics, Drug Discovery.

Source: Alion Venture capital Oct 26, 2026
Investments
134
39 of them startups
Hiring now
63
1,055 open roles
Deals in 12 months
2
1 as the lead
Rounds in 12 months
10
$439M raised
Exits
51

Companies Foresite Capital has invested in

Kymathera Series B $80M · this month round in the pressOct 6
Genomics Genomics & Genetic Testing · United Kingdom Venture round · 1 mo ago 10 roles portfolio pageSep 25
Stepful Medical Education & Training · United States Venture round $55M · 3 mo ago 35 roles portfolio pageOct 2
bit.bio Synthetic Biology · United Kingdom Venture round · 6 mo ago portfolio pageSep 25
Pinnacle Medicines Drug Discovery Series B $89M · 7 mo ago portfolio pageOct 2
Slate Medicines Neurology & CNS Therapeutics · United States Series A $130M · 8 mo ago portfolio pageOct 2
InDomo Digital Marketing Venture round $25M · 11 mo ago lead 1 role round in the pressNov 5, 2025
Kriyatx Drug Discovery · United States Venture round $320.8M · 14 mo ago 3 roles portfolio pageSep 25
Thyme Care Care Coordination & Population Health · United States Venture round $97M · 18 mo ago 1 role portfolio pageOct 2
Spear Diagnostic Tests & IVD Venture round $45M · 2 yr ago 13 roles portfolio pageOct 2
Alumis Immunology & Inflammation Therapeutics · United States Venture round $40M · 2 yr ago 4 roles portfolio pageSep 25
Element Biosciences Laboratory Equipment · United States Series D $277M · 2 yr ago 14 roles portfolio pageSep 25
NGM Bio Drug Discovery · United States Venture round $142M · 2 yr ago portfolio pageSep 25
CASI Pharmaceuticals Biologics & Biosimilars · China Venture round $15M · 2 yr ago portfolio pageSep 25
Optinose Prescription Drugs · United States Venture round $4.7M · 2 yr ago portfolio pageOct 2
Zura Bio Immunology & Inflammation Therapeutics · United States Venture round $112.5M · 2 yr ago 5 roles portfolio pageOct 18
Adurolife Wellness Programs · United States Venture round $5.1M · 2 yr ago portfolio pageSep 25
Engrail Therapeutics Prescription Drugs Series B $157M · 2 yr ago portfolio pageSep 25
Voyager Therapeutics Neurology & CNS Therapeutics · United States Venture round $20M · 2 yr ago portfolio pageOct 2
ImageneBio Immunology & Inflammation Therapeutics · United States Venture round $42.6M · 3 yr ago portfolio pageSep 25
Evonetix Web Hosting & VPS Venture round $24M · 3 yr ago portfolio pageSep 25
Inscripta is now Manus Livestock · United States Venture round $27.8M · 3 yr ago portfolio pageSep 25
DELFI Diagnostics Diagnostic Tests & IVD · United States Venture round $225M · 4 yr ago 4 roles portfolio pageSep 25
DNAnexus Bioinformatics · United States Venture round $200M · 4 yr ago portfolio pageSep 25
Bellicum Venture round $35M · 4 yr ago portfolio pageSep 25
HealthVerity Health Data & Interoperability · United States Venture round $100M · 5 yr ago 17 roles portfolio pageSep 25
Tessera Therapeutics Rare Disease Therapeutics · United States Venture round $230M · 5 yr ago 3 roles portfolio pageOct 2
Crossover Health Primary Care & Medical Centers Series D $168M · 5 yr ago 1 role portfolio pageSep 25
Everlywell Diagnostic Tests & IVD · United States Venture round $75M · 5 yr ago 9 roles portfolio pageSep 25
Affinivax Venture round $226M · 5 yr ago portfolio pageSep 25
SomaLogic Venture round $212M · 5 yr ago portfolio pageOct 2
Verona Pharma Venture round $200.2M · 6 yr ago portfolio pageOct 2
Compass Therapeutics Drug Discovery · United States Venture round $60.5M · 6 yr ago 3 roles portfolio pageSep 25
insitro Drug Discovery AI · United States Venture round $143M · 6 yr ago 14 roles portfolio pageSep 25
Verastem Oncology Drug Discovery · United States Venture round $100M · 6 yr ago 6 roles portfolio pageOct 2
Unknown Domain Venture round $111.5M · 6 yr ago portfolio pageSep 25
Datavant Health Data & Interoperability · United States Venture round $36.4M · 8 yr ago 56 roles portfolio pageSep 25
Venatorx Venture round $42M · 9 yr ago portfolio pageOct 2
RxSight Ophthalmology & Eye Clinics · United States Venture round $50M · 9 yr ago 10 roles portfolio pageOct 2
Adapt Immune Cell & Gene Therapy Venture round · 12 yr ago portfolio pageSep 25
Natera Genomics & Genetic Testing · United States 154 roles portfolio pageSep 25
Hinge Health Telemedicine & Virtual Care · United States 72 roles portfolio pageSep 25
Cytokinetics Cardiometabolic Therapeutics · United States 57 roles portfolio pageSep 25
Lundbeck Neurology & CNS Therapeutics · Denmark 44 roles portfolio pageSep 25
Replimune Oncology Therapeutics · United States 39 roles portfolio pageOct 2
Signant Health Clinical Trial Software 34 roles portfolio pageOct 2
Ascendis Pharma Prescription Drugs · Denmark 32 roles portfolio pageSep 25
Madrigal Pharmaceuticals Prescription Drugs · United States 31 roles portfolio pageSep 25
Xaira Therapeutics Drug Discovery AI · United States 28 roles portfolio pageOct 2
uniQure Cell & Gene Therapy · United States 27 roles portfolio pageOct 2
Sollis Health Urgent & Emergency Care · United States 23 roles portfolio pageOct 2
Xenon Pharmaceuticals Prescription Drugs · Canada 24 roles portfolio pageOct 2
Wave Life Sciences Drug Discovery · United States 24 roles portfolio pageOct 2
Olema Oncology Prescription Drugs · United States 21 roles portfolio pageOct 2
Veracyte Diagnostic Tests & IVD 19 roles portfolio pageOct 18
Centessa Pharmaceuticals Prescription Drugs · United States 13 roles portfolio pageSep 25
Parabilis Medicines Prescription Drugs 16 roles portfolio pageOct 2
Disc Medicine United States 15 roles portfolio pageSep 25
UpDoc Telemedicine & Virtual Care · United States 14 roles portfolio pageOct 18
Color Telemedicine & Virtual Care · United States 12 roles portfolio pageSep 25
ConnectiveRx Revenue Cycle & Medical Billing · United States 11 roles portfolio pageSep 25
GRAIL Diagnostic Tests & IVD · United States 13 roles portfolio pageSep 25
Latigo Biotherapeutics Recommendation Systems 11 roles portfolio pageSep 25
Allogene Therapeutics Cell & Gene Therapy · United States 10 roles portfolio pageSep 25
Syndax Oncology Therapeutics · United States 7 roles portfolio pageOct 2
Bicara Therapeutics Biologics & Biosimilars 6 roles portfolio pageSep 25
Invivyd Biologics & Biosimilars · United States 7 roles portfolio pageSep 25
Kura Oncology Oncology Therapeutics · United States 7 roles portfolio pageSep 25
Jade Biosciences Biologics & Biosimilars · United States 6 roles portfolio pageSep 25
Lyell Cell & Gene Therapy · United States 4 roles portfolio pageSep 25
Aura Biosciences Drug Discovery · United States 3 roles portfolio pageSep 25
Novavax Vaccines · Sweden 3 roles portfolio pageSep 25
Foresite Labs Angel Networks & Startup Accelerators 2 roles portfolio pageSep 25
Pharvaris APIs & Drug Manufacturing 2 roles portfolio pageOct 2
Adicet Bio Oncology Therapeutics · United States 1 role portfolio pageSep 25
Arcus Biosciences Prescription Drugs 1 role portfolio pageSep 25
Blueprint Medicines Oncology Therapeutics 1 role portfolio pageSep 25
Crinetics Drug Discovery · United States 1 role portfolio pageSep 25
Galileo Telemedicine & Virtual Care 1 role portfolio pageSep 25
Karyopharm Prescription Drugs · United States 1 role portfolio pageSep 25
Mammoth Biosciences Synthetic Biology · United States 1 role portfolio pageSep 25
MyOme Genomics & Genetic Testing 1 role portfolio pageSep 25
89bio Biologics & Biosimilars portfolio pageSep 25
Biohaven Biologics & Biosimilars portfolio pageSep 25
Bruker Spatial Biology Payment Processing & Gateways · United States portfolio pageSep 25
Cerevance Prescription Drugs portfolio pageSep 25
CG Oncology Cell & Gene Therapy portfolio pageSep 25
Corvus Pharmaceuticals, Inc. Biologics & Biosimilars portfolio pageSep 25
cuehealth.com United States portfolio pageSep 25
12

Focus

Markets
Prescription Drugs13%
Oncology Therapeutics11%
Drug Discovery11%
Biologics & Biosimilars7%
Genomics & Genetic Testing7%
Cell & Gene Therapy6%
Rare Disease Therapeutics4%
Neurology & CNS Therapeutics4%
Where its companies are
United States41%
United Kingdom2%
Denmark1%
China1%
Germany1%
Ireland1%
Sweden1%
Canada1%
Stage of its companies
Venture, series not stated85%
Series B8%
Series C and later5%
Series A3%

Questions about Foresite Capital

How many companies has Foresite Capital invested in?

Foresite Capital is known to hold 134 companies: 39 startups, and 51 exits so far, read from its own portfolio page and the funding rounds that name it.

Is Foresite Capital investing now?

Yes: in the last 12 months 2 rounds in the press named Foresite Capital (1 as the lead), and 4 companies joined its portfolio page in 90 days.

What does Foresite Capital invest in?

The markets of the companies Foresite Capital holds: Prescription Drugs (13%), Oncology Therapeutics (11%), Drug Discovery (11%), Biologics & Biosimilars (7%), Genomics & Genetic Testing (7%).

Which Foresite Capital portfolio companies are hiring?

63 companies Foresite Capital holds are hiring now, with 1,055 open roles listed on this page.

Who does Foresite Capital invest alongside?

The investors that hold the most companies together with Foresite Capital: RA Capital Management, OrbiMed, Aisling Capital, GV, Nextech Invest.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Sources: its portfolio page, read Oct 25; 2 rounds in the press that name it

Foresite Capital portfolio: 134 known companies. Alion, Oct 26, 2026. https://alion.io/company/foresite-capital/portfolio

Licence: CC BY-SA 4.0JSON